S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)

ZimVie (ZIMV) Stock Forecast, Price & News

$9.67
+0.08 (+0.83%)
(As of 09/22/2023 ET)
Compare
Today's Range
$9.51
$9.76
50-Day Range
$9.59
$14.12
52-Week Range
$5.05
$15.50
Volume
104,175 shs
Average Volume
464,707 shs
Market Capitalization
$256.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

ZimVie MarketRank™ Forecast

Analyst Rating
Sell
1.00 Rating Score
Upside/​Downside
13.8% Upside
$11.00 Price Target
Short Interest
Healthy
1.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
32.81%
From $0.64 to $0.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.57 out of 5 stars

Medical Sector

787th out of 968 stocks

Dental Equipment & Supplies Industry

4th out of 5 stocks


ZIMV stock logo

About ZimVie (NASDAQ:ZIMV) Stock

ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZIMV Price History

ZIMV Stock News Headlines

Here’s Why ZimVie (ZIMV) Advanced in Q2
ZimVie (NASDAQ: ZIMV)
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
ZimVie Announces FDA Approval for New Mobi-C® Implant
Here’s Why ZimVie (ZIMV) Declined in Q1
Q1 2023 ZimVie Inc Earnings Call
ZimVie (ZIMV) Q1 2023 Earnings Call Transcript
See More Headlines
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Company Calendar

Last Earnings
8/02/2023
Today
9/22/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.00
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+13.8%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$-63,880,000.00
Pretax Margin
-11.94%

Debt

Sales & Book Value

Annual Sales
$913.86 million
Cash Flow
$6.40 per share
Book Value
$29.08 per share

Miscellaneous

Free Float
25,731,000
Market Cap
$256.55 million
Optionable
Not Optionable
Beta
1.40

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Vafa Jamali (Age 53)
    Pres, CEO & Director
    Comp: $1.41M
  • Mr. Richard J. Heppenstall (Age 52)
    Exec. VP, CFO & Treasurer
    Comp: $749.83k
  • Mr. Indraneel Kanaglekar (Age 45)
    Sr. VP & Pres of Global Dental
    Comp: $534.5k
  • Ms. Rebecca A. Whitney (Age 46)
    Sr. VP & Pres of Global Spine
    Comp: $622.97k
  • Mr. Benjamin Hutson
    Sr. VP of Operations
  • Sandra Schneider
    Chief Accounting Officer
  • Mr. Steve Rondeau
    Sr. VP & Chief Information Officer
  • Ms. Heather Kidwell (Age 54)
    Sr. VP, Chief Legal, HR & Compliance Officer and Corp. Sec.
  • Ms. Laura Driscoll
    VP of Communications
  • Mr. Michael Minette
    Sr. VP of Strategy & Corp. Devel.













ZIMV Stock - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" ZIMV shares.
View ZIMV analyst ratings
or view top-rated stocks.

What is ZimVie's stock price forecast for 2023?

1 equities research analysts have issued 12 month price objectives for ZimVie's stock. Their ZIMV share price forecasts range from $11.00 to $11.00. On average, they expect the company's share price to reach $11.00 in the next twelve months. This suggests a possible upside of 13.8% from the stock's current price.
View analysts price targets for ZIMV
or view top-rated stocks among Wall Street analysts.

How have ZIMV shares performed in 2023?

ZimVie's stock was trading at $9.34 at the start of the year. Since then, ZIMV shares have increased by 3.5% and is now trading at $9.67.
View the best growth stocks for 2023 here
.

When is ZimVie's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our ZIMV earnings forecast
.

How were ZimVie's earnings last quarter?

ZimVie Inc. (NASDAQ:ZIMV) issued its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.20. The firm had revenue of $224.90 million for the quarter, compared to analyst estimates of $212.36 million. ZimVie had a positive trailing twelve-month return on equity of 3.80% and a negative net margin of 9.27%.

What ETF holds ZimVie's stock ?

Schwab Ariel ESG ETF holds 1,617 shares of ZIMV stock, representing 0.08% of its portfolio.

What guidance has ZimVie issued on next quarter's earnings?

ZimVie issued an update on its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $0.50-$0.70 for the period, compared to the consensus estimate of $0.46. The company issued revenue guidance of $850.00 million-$870.00 million, compared to the consensus revenue estimate of $849.00 million.

What is ZimVie's stock symbol?

ZimVie trades on the NASDAQ under the ticker symbol "ZIMV."

Who are ZimVie's major shareholders?

ZimVie's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.35%), Kent Lake Capital LLC (5.19%), Divisadero Street Capital Management LP (3.77%), Acadian Asset Management LLC (2.54%), State Street Corp (1.83%) and Charles Schwab Investment Management Inc. (1.79%). Insiders that own company stock include Richard Heppenstall, Sally Crawford and Vafa Jamali.
View institutional ownership trends
.

How do I buy shares of ZimVie?

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZimVie's stock price today?

One share of ZIMV stock can currently be purchased for approximately $9.67.

How much money does ZimVie make?

ZimVie (NASDAQ:ZIMV) has a market capitalization of $256.55 million and generates $913.86 million in revenue each year. The company earns $-63,880,000.00 in net income (profit) each year or ($3.16) on an earnings per share basis.

How many employees does ZimVie have?

The company employs 2,700 workers across the globe.

How can I contact ZimVie?

The official website for the company is www.zimvie.com. The company can be reached via phone at 303-443-7500 or via email at marissa@gilmartinir.com.

This page (NASDAQ:ZIMV) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -